The clinical management of obesity and long-term metabolic dysfunction in the United States has entered a highly advanced phase. While early therapeutic breakthroughs introduced weekly molecules to the market, modern pharmacological research heavily emphasizes diverse dosing schedules to accommodate unique lifestyle demands and variations in patient tolerance. At the forefront of this expanding medical field […]